Drugs / Testosterone undecannoate
last change Mar 2015 re-read 2 minutes ago

Testosterone undecannoate

Developed for
pituitary deficiency

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01397500 Comparator Nov 2011 → Feb 2015 pituitary deficiency Max-Planck-Institute of Psychiatry Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Testosterone undecannoate ClinicalTrials.gov intervention name — accepted as the source's own label NCT01397500
Action Restore “testosterone replacement in gonadotropin deficient patients compared to placebo treated control patients” NCT01397500
Route Intramuscular “Testosterone undecannoate administered twice (6 week Interval) im by investigator.” NCT01397500